STOCK TITAN

Aurora Cannabis Inc. Common Shares - ACB STOCK NEWS

Welcome to our dedicated page for Aurora Cannabis Common Shares news (Ticker: ACB), a resource for investors and traders seeking the latest updates and insights on Aurora Cannabis Common Shares stock.

Aurora Cannabis Inc. (NASDAQ: ACB, TSX: ACB) is a prominent Canadian company headquartered in Edmonton, Alberta, dedicated to the cultivation, production, and sale of high-quality cannabis for both medical and recreational use. The company's state-of-the-art facilities in Alberta embody advanced cultivation techniques that ensure the highest standards of quality, reliability, and safety in their products. Aurora's comprehensive portfolio includes renowned brands like Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, catering to a wide range of consumer preferences.

Aurora's operations extend beyond Canada, with significant international presence through medical cannabis exporting agreements. A notable subsidiary, Australis Capital Inc., plays a crucial role in participating in the U.S. cannabis market. The company's commitment to quality is further highlighted by its EU-GMP and TGA-GMP certified production facilities, ensuring compliance with rigorous international standards.

In recent developments, Aurora has launched three new cannabis-infused beverages targeted initially at veteran patients. These products, featuring innovative SōRSE® emulsion technology, offer an alternative form of cannabis consumption without the strong cannabis aroma or taste. Available in flavors like Neon Rush, Strawberry Pineapple Tropical Fizz, and Pineapple Coconut Fizz, these beverages are designed to enhance patient wellbeing with a refreshing and potent experience.

Financially, Aurora has achieved significant milestones, including the repayment of nearly $465 million in convertible debt and forecasting positive free cash flow for calendar 2024. The company has also strengthened its global footprint by acquiring MedReleaf Australia's majority equity, further solidifying its position in the Australian market. Aurora’s commitment to financial discipline and strategic expansions underscores its potential for sustainable growth.

Aurora's dedication to innovation and patient care is exemplified through its continuous development of new products and partnerships. Their recent launches include resin cartridges and pastilles in Australia, expanding their product range and enhancing patient access to premium medical cannabis. Additionally, the company's strategic moves in Europe, particularly in Germany, position it as a leader in the evolving cannabis landscape.

With a robust pipeline of products and strategic market expansions, Aurora Cannabis Inc. continues to pave the way for significant advancements in the global cannabis industry, committed to improving lives through high-quality, innovative cannabis products.

Rhea-AI Summary

High Tide Inc. has transitioned all Canna Cabana retail cannabis stores to a discount club model, enhancing its presence in the value segment and claiming the title of North America's largest cannabis discount retailer. The Cabana Club loyalty program offers exclusive low prices and benefits to over 245,000 members. This strategy aims to capture market share from the illicit cannabis sector, which accounts for 40% of sales, and reflects a successful pilot program that showed significant sales increases. High Tide plans to expand this model across Canada and potentially globally, leveraging its in-house brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags
none
-
Rhea-AI Summary

High Tide has finalized its acquisition of an 80% stake in Blessed CBD for £9,064,000, enhancing its global e-commerce footprint. This marks High Tide's fifth e-commerce acquisition in 2021, increasing its e-commerce revenue run-rate from approximately $10.6 million to nearly $60 million. Blessed CBD, a leading CBD brand in the U.K. with significant site traffic, reported £5.1 million in revenue and £2.8 million in EBITDA for the year ending August 2021. The deal also includes options for High Tide to acquire the remaining 20% of Blessed CBD in three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.66%
Tags
-
Rhea-AI Summary

High Tide Inc. has announced a definitive agreement to acquire 80% of Enigmaa Ltd., operating as Blessed CBD, for £9.06 million. Blessed is a leading UK CBD brand, known for its direct-to-consumer model with £5.1 million in revenue and strong gross margins of 81%. This acquisition aims to enhance High Tide's UK e-commerce presence and capitalize on cross-selling opportunities. The deal is expected to close in October 2021, with an option for High Tide to acquire the remaining 20% in three years, positioning the company for further growth in the EU CBD market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
Rhea-AI Summary

High Tide Inc. has opened two new retail cannabis stores in Windsor and Cornwall, Ontario, increasing its total to 101 locations in Canada and 30 in Ontario. September has seen the launch of eight new stores, underlining the company's growth despite pandemic-related challenges. The Windsor store is strategically located in a commercial district, while the Cornwall outlet sits in a prominent retail plaza. To celebrate its 100-store milestone, High Tide will support World Vision by sponsoring two additional children for each new store. The company aims to exceed 200 locations nationally by 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
-
Rhea-AI Summary

Aurora Cannabis has launched Bidiol, the first domestically produced medical cannabis oil in Uruguay, available in 3% and 10% concentrations. This launch is a key component of Aurora's renewed strategy focusing on the Uruguayan market, aiming to establish the country as a center for medical cannabis production. The oil is authorized for treating refractory epilepsy in children and adolescents and is available in pharmacies. Aurora plans to expand its CBD oil portfolio in Uruguay shortly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
-
Rhea-AI Summary

Aurora Cannabis (ACB) reported a 9% increase in total medical cannabis net revenue year-over-year, reaching $35 million. The company achieved an adjusted gross margin of 68% and narrowed its adjusted EBITDA loss by $17.6 million to $13.9 million. However, total cannabis net revenue decreased to $54.8 million, a 19% decline compared to the previous year. Aurora maintains a robust cash position of $440.9 million and announced cost savings of $60 to $80 million through its business transformation plan. The company aims for adjusted EBITDA profitability in the near future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.66%
Tags
Rhea-AI Summary

High Tide Inc. has been recognized as one of Canada’s top growing companies for 2021 by the Globe and Mail, ranking 82nd out of 448 firms with a remarkable three-year revenue growth of 733%. This recognition highlights High Tide's operational success since its first cannabis retail store opened in October 2018, growing from 160 employees to nearly 100 stores and over 900 employees. The Company plans to enhance revenue through further retail and e-commerce expansion in Canada, the United States, and Europe.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.25%
Tags
none
-
Rhea-AI Summary

Aurora Cannabis Inc. (ACB) has rescheduled its conference call to discuss the fourth quarter and full fiscal year 2021 results to Monday, September 27, 2021, at 5:00 p.m. ET. The financial results and related annual disclosure documents will be released after market close on the same day. CEO Miguel Martin and CFO Glen Ibbott will host the call, allowing investors to submit questions via a designated weblink. Aurora, headquartered in Edmonton, Alberta, is a leader in the cannabis industry, focusing on high-quality cannabis products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
-
Rhea-AI Summary

High Tide Inc. has revealed its new cannabis retail concept, Cannabis Chop Club, aimed at value-focused consumers. The stores will be smaller, averaging 1,000-1,200 square feet, and have lower build costs of $125,000 to $150,000. The Chop Club will offer exclusive deals for members and leverage High Tide’s existing loyalty programs. CEO Raj Grover highlights the potential to capture market share from the illicit cannabis market. The company, known for its retail cannabis and consumption accessories, operates 93 locations in Canada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
none
Rhea-AI Summary

Aurora Cannabis (NASDAQ: ACB; TSX: ACB) will discuss its fourth quarter and full fiscal year 2021 results on September 21, 2021, at 5:00 p.m. ET. The financial results will be released after market close on the same day. The call will be hosted by CEO Miguel Martin and CFO Glen Ibbott, allowing investors to submit questions through the provided web link. The company will also conduct its Annual General Meeting virtually on November 12, 2021, at 12:00 p.m. ET.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
conferences earnings

FAQ

What is the current stock price of Aurora Cannabis Common Shares (ACB)?

The current stock price of Aurora Cannabis Common Shares (ACB) is $4.27 as of December 20, 2024.

What is the market cap of Aurora Cannabis Common Shares (ACB)?

The market cap of Aurora Cannabis Common Shares (ACB) is approximately 225.0M.

What is Aurora Cannabis Inc. primarily known for?

Aurora Cannabis Inc. is known for the cultivation, production, and sale of high-quality cannabis products for both medical and recreational use.

Where is Aurora Cannabis Inc. headquartered?

Aurora Cannabis Inc. is headquartered in Edmonton, Alberta, Canada.

What are some of the brands under Aurora Cannabis?

Some of the brands under Aurora Cannabis include Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard.

What recent products has Aurora Cannabis launched?

Aurora Cannabis recently launched three new cannabis-infused beverages and resin cartridges in Australia, catering to patient needs with innovative and high-quality products.

What is Aurora's financial outlook for 2024?

Aurora expects to achieve positive free cash flow in calendar 2024 and has recently completed the repayment of nearly $465 million in convertible debt.

What significant acquisitions has Aurora made recently?

Aurora acquired the remaining equity interest in MedReleaf Australia, strengthening its position in the Australian medical cannabis market.

What certifications do Aurora's production facilities hold?

Aurora's production facilities hold EU-GMP and TGA-GMP certifications, ensuring compliance with rigorous international quality standards.

How does Aurora contribute to the U.S. cannabis market?

Aurora's wholly-owned subsidiary, Australis Capital Inc., actively participates in the U.S. cannabis market.

What international operations does Aurora have?

Aurora has expanded internationally through medical cannabis exporting agreements, with a significant presence in Europe and Australia.

How does Aurora ensure the quality of its products?

Aurora ensures the quality of its products through advanced cultivation techniques and compliance with international standards like EU-GMP and TGA-GMP.

Aurora Cannabis Inc. Common Shares

Nasdaq:ACB

ACB Rankings

ACB Stock Data

225.00M
54.75M
13.04%
7.99%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Edmonton